Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

JAMA. 2021 Jun 22;325(24):2500-2502. doi: 10.1001/jama.2021.6564.

Abstract

This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Asymptomatic Infections / epidemiology
  • BNT162 Vaccine
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / prevention & control
  • COVID-19 Vaccines*
  • Female
  • Humans
  • Male
  • Mass Screening
  • Middle Aged
  • Personnel, Hospital*
  • Retrospective Studies

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine